Sign in
Not yet recruitingPhase 2

Mesotherapy as a treatment for irritable bowel syndrome

Tests mesotherapy, small skin injections, in adults with irritable bowel syndrome.

Key facts

Who runs it
Polyclinique De L'europe
Where
France1 site in 1 countryChoose a country to see its sites
Registry title
Mesotherapy treatment of irritable bowel syndrome
Status
Not yet recruiting
Phase
Phase 2
People taking part
27 people, planned
Started
15 Jan 2024
Planned end
15 Jan 2026
Type of study
Interventional
Record updated
8 February 2024

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with irritable bowel syndrome, to test mesotherapy as a treatment.

Age
18 Years and older
Sex
All sexes can join

Main reasons for not taking part

  • Healthy volunteers cannot join

Where is this trial?

It has sites in one country. Choose a country to see its sites.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Plain-language title
Mesotherapy as a treatment for irritable bowel syndromeGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
8 February 2024